CONTACTS
SUBJECTS
CBC Lab WBC 12.8 Elevated Blister Big Toe Left Foot VA for Meeting D
2903 -
2903 - ..
2904 - Summary/Objective
2905 -
290501 - Follow up ref SDS 68 0000. ref SDS 62 0000.
290502 -
290503 -
290504 -
290505 -
290506 -
290508 - ..
2906 -
2907 -
2908 - Background
2909 -
290901 - On 131016 1632 submit letter for agenda meeting to review lab results
290902 - scheduled 131017 1000. ref SDS 41 X45G
290904 - ..
290905 - On 140131 0815 ordered another lab - cbc, electrolytes, lipid with NMR
290906 - - from Labcor to get LDL-P. ref SDS 50 X45G
290908 - ..
290909 - On 140201 1159 had full lab with NMR lipid panel drawn at John Muir
290910 - Hospital on Treat, and by Labcorp. ref SDS 51 RP4N
290912 - ..
290913 - On 140203 1147 had partial lab drawn at VA in Martinez. ref SDS 52
290914 - KK9M
290916 - ..
290917 - On 140507 0857 ordered another full lab from Labcorp with NMR lipid
290918 - panel. ref SDS 58 OO5G
290920 - ..
290921 - On 140508 1133 lab blood daw at Labcorp with John Muir Medical Center
290922 - on Treat Blvd in Concord. ref SDS 59 445G
290924 - ..
290925 - On 140514 0950 VA partial lab at Medical Center in San Francisco.
290926 - ref SDS 62 X45G
290928 - ..
290929 - On 140814 1530 VA full lab at Clinic in Martinez. ref SDS 68 X45G
290931 - ..
290932 - On 140827 1422 VA partial lab CBC only at Clinic in Martinez re-check
290933 - elevated WBC. ref SDS 72 X45G
290934 -
290935 -
290936 -
290937 -
290939 - ..
2910 -
2911 -
2912 - Progress
2913 -
291301 - Blood draw today at Labcorp located in John Muir Urgent Care facility
291302 - on Treat Blvd, near 680, ordered in another record on 141020 0819.
291303 - ref SDS 73 GR5G
291305 - ..
291306 - Scope of lab...
291307 -
291308 - 1. CBC
291309 - 2. Electrolytes
291310 - 3. Urinalysis
291311 - 4. Lipid NMR panel
291313 - ..
291314 - However, turned out that Health Testing Centers omitted Lipid NMR
291315 - panel, due to coding error, reported in the record on 141020 0819.
291316 - ref SDS 73 AT3I
291318 - ..
291319 - See directory structure for medical records on 140320 1125.
291320 - ref SDS 56 4M5I
291321 -
291322 -
291324 - ..
291325 - CBC WBC 9.5 Increased 50% After Several Years Stable
291326 - Blood Tests Evaluate Health 5 Years After CABG x4 Surgery
291327 -
291328 - Follow up ref SDS 68 RP4N, ref SDS 62 RP4N.
291329 -
291330 - Prior VA CBC on 120509 1108. ref SDS 26 RP4N
291331 - Prior VA CBC on 120831 1524. ref SDS 27 RP4N
291332 - Prior VA CBC on 121130 1001. ref SDS 31 RP4N
291333 - Prior VA CBC on 130529 0818. ref SDS 38 RP4N
291334 - Prior Labcorp CBC on 140201 1159. ref SDS 51 RP4N
291335 - VA did not order CBC for lab on 140203 1147. ref SDS 52 YX8K
291336 - Prior Labcorp CBC on 140508 1149. ref SDS 59 RP4N
291337 - VA did not order CBC for lab on 140514 0950. ref SDS 62 RP4N
291338 - Prior VA CBC on 140814 1530. ref SDS 68 RP4N
291339 - Prior VA CBC on 140827 1413. ref SDS 72 RP4N
291340 -
291342 - ..
291343 - CBC PANEL
291344 - ..
291345 - Dates......... 2014 10 20 1050 140827 140814 140514 140508 140203 140201 130529
291346 - Labcorp VA VA VA Labcorp VA Labcorp VA VA Labcorp
291347 - Blood Results Results Results Results Results Results Results Results Units Range Range
291348 - WBC 13.3 H 13.8 H 12.8 H 9.5 6.2 7.4 K/cmm 4.8 - 10.8 3.4 - 10.8
291349 - RBC 5.64 5.56 5.44 5.21 5.13 5.09 M/cmm 4.7 - 6.1 4.14 - 5.80
291350 - HGB 16.5 16.4 16.2 15.1 15.2 15.0 g/dL 14 - 18 12.6 - 17.7
291351 - HCT 50.1 48.8 48.3 47.0 44.2 46.2 % 42 - 52 37.5 - 51.0
291352 - MCV 89.0 87.8 88.7 90.0 86.0 90.7 fL 80 - 99 79.0 - 97.0
291353 - MCH 29.3 29.5 29.8 29.0 29.6 29.5 uug 27 - 34 26.6 - 33.0
291354 - MCHC 32.9 33.6 33.6 32.1 34.4 32.5 gm/dL 32 - 35.2 31.5 - 35.7
291355 - RDW 14.3 13.9 13.9 13.8 13.7 14.4 % 11.5 - 14.5 12.3 - 15.4
291356 - PLT 341.0 322.0 295.0 329 303 279 K/cmm 130 - 400 155.0 - 379.0
291357 - MPV 9.1 8.3 8.8 fL 7 - 10.4
291358 - NEUT % 80.0 74.2 78.1 70 69 69.9 % 40 - 80 40.0 - 74.0
291359 - LYMPH % 13.0 14.9 L 13.6 L 20 21 L 19.7 % 20 - 51 14.0 - 46.0
291360 - MONO % 7.0 9.8 7.6 8 8 7.8 % 2 - 13 4.0 - 12.0
291361 - EOS % 0.0 0.3 L 0.4 L 1 1 1.9 % .5 - 7 0.0 - 5.0
291362 - BASO % 0.9 0.8 0.3 1 1 0.7 % 0 - 2 0.0 - 3.0
291363 - NEUT # 10.5 H 10.3 H 10.0 H 6.7 4.3 5.2 K/cmm 1.5 - 7.9 1.4 - 7.0
291364 - LYMPH # 1.7 2.1 1.7 1.9 1.3 1.5 K/cmm 1.2 - 3.4 0.7 - 3.1
291365 - MONO # 0.9 1.3 H 1.0 0.7 0.5 0.6 K/cmm .2 - 1.2 0.1 - 0.9
291366 - EOS # 0.0 0.9 L 0.1 0.1 0.1 0.1 K/cmm .1 - .5 0.0 - 0.4
291367 - BASO # 0.0 0.1 0.0 0.1 0.1 0.1 K/cmm 0 - .2 0.0 - 0.2
291368 - ESRmVES mm/hr 0 - 10
291369 - ESRxCYT mm/hr 2 - 10
291370 - RETIC % % .66 - 2.85
291371 - RETIC # k/uL 27.9 - 121.6
291372 - Immature Granulocytes 0.0 0.0 0.0 % 0.0 - 2.0
291373 - Immature Grans (Abs) 0.0 0.0 0.0 % 0.0 - 0.1
291375 - ..
291376 - Comments:
291377 -
291378 - a. Test Performed at...
291379 - Health Testing Centers
291380 - 2760 W. OAKLAND PARK BLVD.
291381 - FORT LAUDERDALE FL 33311
291382 -
291384 - ..
291385 - Background Elevated WBC
291386 -
291387 - Increased exercise explained on 140814 1530, ref SDS 68 I17G, may have
291388 - stimulated bone marrow to produce more new blood that increased WBC
291389 - 30% in VA blood test on 140814, per above, ref SDS 68 FK6I, explained
291390 - by Doctor Johnson during a meeting at Kaiser on 030606. ref SDS 1 JP7G
291391 - However, this effect was significantly less, WBC 9.5, in prior lab on
291392 - 140508, and at that time exercise was more than twice the level of
291393 - effort that occurred during the several months prior to the lab on
291394 - 140814.
291396 - ..
291397 - Recent infection on left big toe may have elevated WBC 12.8 in VA lab
291398 - on 140814 1530. ref SDS 68 PS6G This was noted in letter to Primary
291399 - Care later today on 140814 2227, ref SDS 69 K055, citing possible side
291400 - effect from treatment for regression of atherosclerosis.
291402 - ..
291403 - On 140819 0800 Doctor Sandhu in Primary Care examined blister on big
291404 - toe left foot, and determined healing was occurring; no treatment was
291405 - prescribed. Ordered follow up CBC lab to re-check WBC for indication
291406 - of continued infection. ref SDS 71 318I
291408 - ..
291409 - On 140826 follow lab for CBC shows WBC 13.8 went up instead of going
291410 - down, ref SDS 72 FK6I, as expected. This might indicate continued
291411 - mild infection of toe blister, and compounded with acalasia symptoms
291412 - of swallowing difficulties, shown in the record of vomitting the past
291413 - few months possibly due to omitting injections of triamcinolone
291414 - steriods during EGD dilation reported on 140509 0900. ref SDS 60 O36G
291416 - ..
291417 - Prior to Heller Myotomy surgery to recover from achalasia on 091216
291418 - 0600, ref SDS 8 KE9U, WBC was elevated for several years. On 050816,
291419 - Doctor Sandhu reported WBC elevated and ordered retest. ref SDS 2 G540
291420 - CBC retest was ordered and WBC remained high on 050818, so the doctor
291421 - prescribed antibiotics. ref SDS 3 BM8O Initial diagnosis of achalasia
291422 - cited persistent elevated WBC part of patient profile, reported on
291423 - 051202 1430. ref SDS 4 H26M
291425 - ..
291426 - Work plan - perform EGD dilation scheduled at VA in Sacramento on
291427 - 140907 0800 with Doctor Lee, and evaluate if resolution of swallowing
291428 - problems resolves elevated WBC.
291429 -
291430 -
291431 -
291432 -
291433 -
291434 -
291435 -
2915 -
SUBJECTS
Urinalysis Lab VA No Results
4403 -
440401 - ..
440402 - Urinalysis Ketones Trace Abnormal Sp Gravity Above Range
440403 -
440404 - Follow up ref SDS 68 0X72, ref SDS 62 0X72.
440405 -
440406 - Prior Urinalysis test on 101207 0906. ref SDS 15 0X72
440407 - Prior Urinalysis test on 120509 1108. ref SDS 26 0X72
440408 - Prior Urinalysis test on 140201 1159. ref SDS 51 0X72
440409 - VA did not order urinalysis for lab on 140203 1147. ref SDS 52 0X72
440410 - Prior Labcorp CBC on 140508 1149. ref SDS 59 0X72
440411 - Prior Urinalysis test on 140814 1530. ref SDS 68 0X72
440413 - ..
440414 - URINALYSIS PANEL
440415 - ..
440416 - Dates.......... 2014 10 20 1050 140814 140514 140203 140201 120509
440417 - Labcorp VA VA Labcorp VA Labcorp VA VA Labcorp
440418 - Results Results Results Results Results Results Results Units Range Range
440419 - PH 6.0 6.0 5.5 5.5 6.0 5 - 9 5.0 - 7.5
440420 - PROTEIN Trace NEG NEG NEG NEG mg/dL NEG - TRACE NEG - TRACE
440421 - GLUCOSE NEG NEG NEG NEG NEG mg/dL Ref: NEG NEG
440422 - KETONES Trace Abnormal 15 Trace Abnormal NEG NEG mg/dL Ref: NEG NEG
440423 - BILI NEG NEG NEG NEG NEG Ref: NEG NEG
440424 - BILIcnf Ref: NEG
440425 - BLOOD TRACE TRACE TRACE TRACE Ref: NEG
440426 - NITRITE, URINE NEG NEG NEG NEG NEG Ref: NEG NEG
440427 - UROBILI 0.2 0.2 0.2 0.2 0.2 EU/dL .2 - 1 0.0 - 1.9
440428 - LEU EST NEG NEG Ref: NEG
440429 - SP.GRAV 1.030 >=1.030 H 1.036 1.026 1.025 1.003- 1.035 1.005 - 1.030
440430 - COLOR YELLOW YELLOW YELLOW YELLOW YELLOW
440431 - APPEAR CLEAR CLEAR CLEAR CLEAR CLEAR
440432 - WBC ESTERASE NEG NEG NEG
440433 - OCCULT BLOOD NEG NEG NEG NEG
440434 - HAYALINE CASTS NORM(0-1) per lpf 0 - 1
440435 - GRANULAR CASTS None per lpf Ref: None
440436 - CELLULAR CASTS None per lpf Ref: None
440437 - RBC/HPF NORM(0-3) per lpf 0 - 3
440438 - BACTERIA NORM(0-1) per lpf 0 - 1
440439 - EPITHELIAL CELLS NORM(0-1) per lpf 0 - 1
440440 - RENAL EPITHELIAL CELLS None per lpf Ref: None
440441 - CALCIUM OXILATE CRYST NORM(0-1) per lpf 0 - 1
440442 - URIC ACID CRYSTALS NORM(0-1) per lpf 0 - 1
440443 - TRIPLE PHOSPHATE CRYST NORM(0-1) per lpf 0 - 1
440444 - AMORPHOUS SEDIMENT None per lpf Ref: None
440445 - MUCOUS None per lpf Ref: None
440446 - TRICHOMONAS None per lpf Ref: None
440447 - YEAST None per lpf Ref: None
440448 - CULTURE REFLEXED No
440449 - TR EPTH None per lpf Ref: None
440450 - Urobilinogen, Semi-On 0.2
440451 - NITRITE, URINE NEG
440452 -
440454 - ..
440455 - Comments:
440456 -
440457 - a. Test Performed at...
440458 - Health Testing Centers
440459 - 2760 W. OAKLAND PARK BLVD.
440460 - FORT LAUDERDALE FL 33311
440462 - ..
440463 - Ketones trace abnormal continues recent labs Ketones 15 review by VA,
440464 - follow up prior lab showning Ketones trace abnormal, reported on
440465 - 140514 0950. ref SDS 62 MT4L
440466 -
440467 -
440468 -
440469 -
440470 -
440471 -
440472 -
440473 -
4405 -
SUBJECTS
Lab Electrolytes Chem Profile Glucose 97 Sodium NA 144 Potasium K 5.
6103 -
610401 - ..
610402 - T Bili 2.2 Hyperbilirubinemia Worse Atorvastatin Ezetimibe
610403 - Potasium K 5.6 Elevated Increased Electrical Problems Heart
610404 - Bun/Creatinine Ratio Elevated Slightly
610405 -
610406 - Follow up ref SDS 68 KK9M, ref SDS 62 KK9M.
610407 -
610408 - Prior CHEM PROFILE on 120509 1108. ref SDS 26 KK9M
610409 - Prior CHEM PROFILE on 120831 1524. ref SDS 27 KK9M
610410 - Prior CHEM PROFILE on 130228 1140. ref SDS 36 KK9M
610411 - Prior CHEM PROFILE on 130529 0818. ref SDS 38 KK9M
610412 - Prior CHEM PROFILE on 131015 0724. ref SDS 40 KK9M
610413 - Prior CHEM PROFILE Labcorp on 140201 1159. ref SDS 51 KK9M
610414 - Prior CHEM PROFILE on 140203 1147. ref SDS 52 KK9M
610415 - Prior CHEM PROFILE Labcorp on 140508 1149. ref SDS 59 KK9M
610416 - Prior CHEM PROFILE on 140520 0732. ref SDS 64 KK9M
610417 - Prior CHEM PROFILE on 140814 1530. ref SDS 68 KK9M
610418 -
610420 - ..
610421 - ELECTROLYTES - CHEM PROFILE
610423 - ..
610424 - Dates..........2014 10 20 1050 140814 140520 140514 140508 140203 140201 131015 130529
610425 - VA VA VA VA Labcorp VA Labcorp VA VA VA Labcorp
610426 - PLASMA Results Results Results Results Results Results Results Results Results Units Range Range
610427 - GLUCOSE H 105 98 98 97 103 98 108 H 120 mg/dL 74 - 118 65.0 - 99.0
610428 - GLUfast mg/dL Ref: <=99
610429 - NA (salt) 144 144 139 144 140 140 139 139 mmol/L 136 - 144 134.0 - 144.0
610430 - K (potasium) 4.3 4.3 H 5.2 H 5.6 H 5.4 4.8 4.3 H 4.9 mmol/L 3.4 - 4.8 3.5 - 5.2
610431 - CL H 108 H 108 102 105 103 102 105 105 mmol/L 98 - 106 97.0 - 108.0
610432 - CO2 29 29 29.0 30.0 37.0 30.0 mmol/L 23 - 33
610433 - AGAP 8.0 mmol/L 5 - 20
610434 - BUN/Creati Ratio H 28 19 H 23 17 20 24 18 mg/dL 8 - 26 10.0 - 22.0
610435 - CREAT 1.13 1.03 0.80 0.97 0.82 0.81 0.83 0.83 mg/dL .5 - 1.1 0.76 - 1.27
610436 - eGFR INA 66 >60 102 79 >60 91 >60 >60 mL/min Ref: >=60 >59
610437 - eGFR IA 76 92 106 mL/min >59
610438 - CALCIUM 9.9 9.1 8.9 9.5 9.3 9.4 9.2 9.2 mg/dL 8.7 - 10.2 8.6 - 10.2
610439 - CA CORR mg/dL 8.7 - 10.2
610440 - PO4 mg/dL 2.4 - 4.5
610441 - MG 85 mg/dL 1.8 - 2.5
610442 - ALK PHO 107 85 86 100 105 84 87 U/L 40 - 125 39.0 - 117.0
610443 - SGOT 27 U/L 5 - 35
610444 - SGPT 28 U/L 7 - 56
610446 - ..
610447 - T. BIL H 2.0 H 2.5 1.2 H 2.2 H 1.3 H 2.1 H 1.6 H 1.7 H 1.3 mg/dL .1 - 1.2 0.0 - 1.2
610448 - D. BILI 0.38 0.3 0.2 0.2 0.32 0.3 0.34 < 0.1 mg/dL .1 - .5 0.00 - 0.40
610449 - Bilirubin, Indir H 1.62 0.98 1.26 H mg/dL 0.10 - 0.80
610450 - AST (SGOT) 31 25 23 26 23 21 20 22 IntUnits/L 8 - 42 0.0 - 40.0
610451 - ALT (SGPT) 30 21 21 17 21 19 17 19 IntUnits/L 5 - 55 0.0 - 44.0
610452 - ALBUMIN 4.8 4.3 3.9 4.6 4.6 4.1 4.4 3.9 4.0 g/dL 3.3 - 5.2 3.6 - 4.8
610453 - PROTEIN 6.9 7.2 6.5 7.5 6.6 6.7 6.5 7.1 7.2 g/dL 6.0 - 8.5 6.0 - 8.5
610454 - Globulin, Total 2.1 2.0 2.1 g/dL 1.4 - 4.5
610455 - A/G Ratio 2.3 2.3 2.1 1.1 - 2.5
610456 - LDH 223 200.0 180.0 IntUnits/L 90 - 208 0.0 - 225.0
610457 - GGT 13 11.0 9.0 IU/L 0.0 - 65.0
610458 - Iron, Serum 146 100.0 114.0 ug/dL 40.0 - 155.0
610459 - AMYLASE Units/L 28 - 100
610460 - LIPASE Units/L 7 - 58
610461 - NH3 mcmol/L 15 - 56
610462 - URIC AC 6.9 5.6 mg/dL 4.8 - 8.7 3.7 - 8.6
610463 - ..
610464 - Cholesterol, Total 174 164.0 162.0 mg/dL 100.0 - 199.0
610465 - Triglycerides 79 55.0 64.0 mg/dL 0.0 - 149.0
610466 - HDL Cholesterol 61 > 39
610467 - LDL Cholesterol 96 0 - 99
610468 - T Chol/HDL ratio 2.8 0.0 - 5.0
610470 - ..
610471 - Comments:
610472 -
610473 - a. Test Performed at...
610474 - Jenny Galloway, MD
610475 - LabCorp San Diego
610476 - 13112 Evening Creek Dr So Ste 200, San Diego, CA 92128-4108
610478 - ..
610479 - For inquiries, the physician may contact Branch:
610480 - 800-762-4344 Lab: 858-668-3700
610482 - ..
610483 - b. Please Note:
610484 -
610485 - T Chol/HDL Ratio Men Women
610486 -
610487 - 1/2 Avg Risk 3.4 3.3
610488 - Avg Risk 5.0 4.4
610489 - 2x Avg Risk 9.6 7.1
610490 - 3x Avg Risk 23.4 11.0
610492 - ..
610493 - Estimated CHD Risk <0.5 times avg 0.0 - 1.0
610494 -
610496 - ..
610497 - The CHD Risk is based on the T Chol/HDL ratio.
610498 - Other factors affect CHD Risk such as hypertension,
610499 - smoking, diabetes, severe obesity, and family history
610500 - of premature CHD.
610501 -
610503 - ..
610504 - Notes on Electrolytes Lab Hyperbilirubinemia Potassium Heart Problems
610505 - Hyperbilirubinemia Potassium Heart Problems Notes on Electrolytes Lab
610506 - Potassium Heart Problems Hyperbilirubinemia Notes on Electrolytes Lab
610507 -
610508 - Follow up ref SDS 68 G34G, ref SDS 62 G34G.
610509 -
610510 - 1. T Bilirubin 2.0................. ref SDS 0 015M
610512 - ..
610513 - Collection DT T Bili Range Source
610514 - 20/10/2014 10:60 2.0 H...0.3 - 1.2.. ref SDS 0 015M
610515 - 14/08/2014 15:28 2.5 H...0.3 - 1.2.. ref SDS 68 WJ5H
610516 - 20/05/2014 10:20 1.2 ....0.3 - 1.2.. ref SDS 64 015M
610517 - 08/05/2014 11:49 1.3 H...0.0 - 1.2.. ref SDS 59 015M
610518 - 03/02/2014 09:52 2.1 H...0.3 - 1.2.. ref SDS 52 015M
610519 - 01/02/2014 12:28 1.6 H...0.0 - 1.2.. ref SDS 51 015M
610520 - 15/10/2013 08:25 1.7 H...0.3 - 1.2.. ref SDS 40 015M
610521 - 29/05/2013 08:18 1.3 H...0.3 - 1.2.. ref SDS 38 1Y9G
610522 - 28/02/2013 08:36 1.3 H...0.3 - 1.2.. ref SDS 36 6S4F
610523 - 31/08/2012 15:24 2.3 H...0.3 - 1.2.. ref SDS 27 NV9M
610524 - 09/05/2012 11:24 2.5 H...0.3 - 1.2.. ref SDS 26 O46K
610525 - 09/02/2012 11:18 1.8 H...0.3 - 1.2.. ref SDS 22 KK9M
610526 - 17/11/2011 14:27 1.3 H.............. ref SDS 20 KK9M
610527 - 13/10/2011 14:35 1.3 H.............. ref SDS 19 GM65
610528 - 27/07/2011 12:58 2.0 H.............. ref SDS 16 GM65
610529 - 07/12/2010 09:17 1.0 ............... ref SDS 15 GM65
610530 - 21/07/2010 08:54 1.3 H.............. ref SDS 11 GM65
610531 - 14/12/2009 1.3 H ............. ref DRP 1 DE4O
610532 - 02/11/2009 0.9 ............... ref DRP 1 LG4L
610533 - 13/08/2009 15:09 1.7 H.............. ref SDS 5 VG8R
610535 - ..
610536 - On 131017 1000 VA medical chart Progress Notes assessment
610537 - reports Doctor Egan diagnosed chronic hyperbilirubinemia.
610538 - ref SDS 42 PSXT
610540 - ..
610541 - Bilirubin 2.5 in lab today, elevated 110% above range shows
610542 - dramatic increase from 1.2 in lab at VA San Francisco Medical
610543 - Center on 140520. ref SDS 64 015M This is highest result for T
610544 - Bili in patient history, may demonstrate chronic side effects
610545 - statin medications causing poor liver function, as reviewed
610546 - previously on prior lab on 140514 0950. ref SDS 62 G34G Side
610547 - effects of peripheral neuropathy in right foot have ebbed and
610548 - flowed, reported on 140510, shown in case study on 120101 0900.
610549 - ref SDS 21 TV6I
610550 -
610551 - [On 140819 0800 during meeting with Doctor Sandhu in
610552 - Primary Care VA Clinic in Martinez, there was no review of
610553 - chronic hyperbilirubinemia, with T Bilirubin 2.5 rising
610554 - 110% above range, ref SDS 70 9K7I, shown in lab ordered by
610555 - the doctor on 140814. ref SDS 68 015M
610557 - ..
610558 - Background on Rosuvastatin causing elevated T Bilirubin with
610559 - associated severe side effects is reported on 121206 0900,
610560 - ref SDS 32 NI9L, and further explained in the record on 121130
610561 - 0846. ref SDS 31 ER4K
610563 - ..
610564 - On 131017 1000 Doctor Egan explained patient history of
610565 - intermittant and mild peripheral neuropathy that correlates
610566 - with persistent elevated T Bilirubin in lab on 131015,
610567 - ref SDS 40 015M, and further reported with vitals, diet and
610568 - exercise since prior meeting at VA on 130603, see case study on
610569 - 120101 0900, ref SDS 21 X14N, suggests intervention is not
610570 - required at this time to improve recovery from side effects
610571 - taking Rosuvastatin. ref SDS 42 LV5J
610573 - ..
610574 - 2. Potasium K 4.3 within range................. ref SDS 0 ZG5O
610575 -
610576 - Until the lab today, potassium (k) has been persistently
610577 - elevated above range for 6 months through several labs,
610578 - reported on 140514 0950. ref SDS 62 TN3M
610580 - ..
610581 - Doctor Egan, referring cardiology physician at Martinez VA,
610582 - noted in a recent letter that meeting at VA Medical Center in
610583 - San Francisco on 140213 0830, ref SDS 55 GT7G, did not address
610584 - elevated potassium in labs performed by Labcorp and VA, shown
610585 - on 140203 1147. ref SDS 52 ZG5O Doctor Egan again notifies
610586 - that this condition of elevated potassium represents exposure
610587 - to "electrical problems" with the heart, reported on 140430.
610588 - ref SDS 57 UV5I
610590 - ..
610591 - Doctor Egan was concerned last year about potasium (K) rising
610592 - above range for good health. He explained potasium effects
610593 - electrical signals to the heart, and so has significance for
610594 - CVD, reported during meeting at VA on 121206 0900. ref SDS 32
610595 - 6K56
610597 - ..
610598 - At that time on 121206, the doctor cited medication conflicts
610599 - as possibly causing elevated potasium. ref SDS 32 FI7L Doctor
610600 - Egan further considered dehydration (urination) caused by
610601 - Rosuvastatin may have skewed lab results for electrolytes on
610602 - 121130, and so ordered re-test. ref SDS 32 6K4J
610604 - ..
610605 - On 121212 0941 re-test lab reported Glucose 111, sodium 139,
610606 - and potasium (K) 4.6, all within range, ref SDS 33 KK9M,
610607 - correcting errors noted by Doctor Egan during meeting at VA on
610608 - 121206 0900. ref SDS 32 6K4J
610610 - ..
610611 - Dramatic decline in hiking the past 6 weeks, shown in case
610612 - study on 120101 0900, ref SDS 21 7718, and reported on the
610613 - agenda for meeting with Doctor Sandhu in Primary Care, which
610614 - was submitted later today in another record on 140814 2227.
610615 - ref SDS 69 K098, may correlate with potassium falling back
610616 - within range.
610617 -
610619 - ..
610620 - 3. Glucose 105..................... ref SDS 0 ZG5O
610621 -
610622 - On 140514 0950 VA lab for HGBA1c 5.6 within range 4 - 6, seems
610623 - to indicate no evident exposure for diabetes. ref SDS 62 H66G
610625 - ..
610626 - 4. Cloride 108..................... ref SDS 0 WJ5H
610627 -
610628 - There is no record on cause and implications of elevated CL.
610629 -
610630 -
610631 -
610632 -
610633 -
610634 -
610635 -
610636 -
6107 -
SUBJECTS
VA Lab Lipid Cholesterol 164 with Medication Hiking 1000 Miles Weigh
8103 -
810401 - ..
810402 - LDL-C 83 LDL-P 851 HDL 67 Hike 1000 Miles Weight Maintain 170
810403 -
810404 - Follow up ref SDS 68 IM9N, ref SDS 62 IM9N.
810405 -
810406 - Poor VA lab results today align with decline Labcorp blood test using
810407 - NMR technology reported last week on 140508 1133. ref SDS 59 5C7M
810408 - This reflects increased hiking and weight control past 3.5 months,
810409 - reported in case study on 120101 0900, ref SDS 21 PYXR, and supported
810410 - with low carb diet (including orange juice) and low dose medication,
810411 - reported on 140513, in the same study. ref SDS 21 ZU5G
810413 - ..
810414 - Prior LIPID PANEL 120509 1108. ref SDS 26 IM9N
810415 - Prior LIPID PANEL 120831 1525. ref SDS 27 IM9N
810416 - Prior LIPID PANEL 130228 1140. ref SDS 36 IM9N
810417 - Prior LIPID PANEL 130529 0818. ref SDS 38 IM9N
810418 - Prior LIPID PANEL 131015 0724, ref SDS 40 IM9N
810419 - Prior LIPID PANEL Labcorp, 140201 1159, ref SDS 51 IM9N
810420 - Prior LIPID PANEL, 140203 1147, ref SDS 52 IM9N
810421 - Prior LIPID PANEL Labcorp, 140508 1149. ref SDS 59 IM9N
810422 - Prior LIPID PANEL, 140814 1530, ref SDS 68 IM9N
810423 -
810425 - ..
810426 - LIPID PANEL
810428 - ..
810429 - Dates..........2014 08 14 1528 140514 140508 140203 140201 131015 130529
810430 - VA VA Labcorp VA Labcorp VA VA VA Labcorp
810431 - NMR LipoProfile Results Results Results Results Results Results Results Units Range Range
810432 - LDL Particle Number
810433 - LDL-P 851.0 861.0 nmol/L < 1000
810434 - Low < 1000
810435 - Moderate 1000 - 1299
810436 - Borderline High 1300 - 1599
810437 - High 1600 - 2000
810438 - Very High > 2000
810440 - ..
810441 - Lipids
810442 - CHOL (a) 161 164 162 160 156 321 H 307 mg/dL 100 - 240 < 200
810443 - (b) 169
810444 - TRIGLYC (a) 72 58 59 47 68 109 85 mg/dL 10 - 190 < 150
810445 - (b) 59
810446 - HDL-C (a) 55 66 67 58 61 50 50 mg/dL Ref: >=35 >= 40
810447 - (b) 67
810448 - LDL-C (a) 92 87 83 93 81 249 H 240 mg/dL Ref: <=131 < 160
810449 - (b) 90
810450 - ** LDL Dir 93 mg/dL 0 - 130
810451 - TRIG NF mg/dL Ref: <=150
810453 - ..
810454 - TG/HDL ratio (a).... 1.31 0.88 0.88 0.81 1.11 < 2.0
810455 - (b).... 0.88
810457 - ..
810458 - Comments
810459 -
810460 - a. Reporting Lab
810461 - Martinez CBOC
810462 - 150 Muir Road
810463 - Martinez, CA 94553 4668
810465 - ..
810466 - b. VA Intretation Risk Factors
810467 -
810468 - Risk Catagory LDL Goal
810469 - CHD and CHD risk equivalents <100 mg/dL
810470 - Multiple (2+) risk factors <130 mg/dL
810471 - 0-1 risk factor <160 mg/dL
810473 - ..
810474 - c. HDL Chol.
810475 -
810476 - Greater than/equal to 60 mg/dL counts as a "negative"
810477 - risk factor; its presence removes 1 risk factor from
810478 - the total count.
810480 - ..
810481 - d. Cholesterol and LDL standards source....
810482 -
810483 - Adult Treatment Panel III (ATP III) JAMA 5/16/ Vol.
810484 - 285 $19.
810486 - ..
810487 - Analysis....
810488 -
810489 - 1. LDL-P 851, ref SDS 59 U45J, represents lower CVD risk and
810490 - improving lipid management. LDL-C 83 increased 2 points from
810491 - prior lab on 140201. It remains low concordant with LDL-P, but
810492 - moving toward discordance. Research indicates healthiest
810493 - cardiovascular condition occurs with lowest risk for CVD, when
810494 - lipids are discordant, with LDL-P low and LDL-C high, shown in
810495 - the record on 131125 0005. ref SDS 46 FI3G
810497 - ..
810498 - VA published goal LDL-C <= 131; Labcorp published goal LCL-C <
810499 - 100. ref SDS 62 5C7M New AHA guidelines show LDL-C < 190,
810500 - reported on 131112 1422. ref SDS 44 HT87
810502 - ..
810503 - VA lowering goal to HDL > 35 from > 40 seems conflicting with
810504 - patient history of CABG +4 on 091022 0700. ref SDS 7 PQWU
810505 - Since HDL 30 was found at that time (see Lipid history below,
810506 - ref SDS 62 W25L, setting the bar at HDL 35 has little tolerance
810507 - for genetic variation to avoid and repair endothelium lesions
810508 - causing atheriosclerotic plaque.
810510 - ..
810511 - NMR test lists LDL-P < 1600 for "borderline" CVD high risk, and
810512 - that below 1000, is "low," risk for CVD. ref SDS 52 U45J Thus,
810513 - LDL-P 851 presents low risk for CVD. Research on 131125, lists
810514 - LDL-P < 700 may be a better target to manage CVD risk.
810515 - ref SDS 46 WY9H The same research also cites LDL-P < 1000 for
810516 - evaluating CVD risk, similar to NMR test today. ref SDS 46 OQ9N
810518 - ..
810519 - When can patients be confident LDL-P < 700, 600, 200 - is low
810520 - enough to work on other aspects of daily life?
810522 - ..
810523 - 2. LDL-P 851 in Labcorp test today on 140508, correlates with
810524 - TG/HDL ratio 59/67 = 0.88. ref SDS 59 5C7M Research indicates
810525 - TG/HDL ratio correlates to LDL-P vaulations produced by NMR
810526 - testing, reported on 131125 0005. ref SDS 46 666G
810528 - ..
810529 - 3. Resting heart rate getting up in the morings has fallen below
810530 - 50. Blood pressure varies - averages about 115 65. After
810531 - hikes about 105 55. Systalic on occassion falls below 100.
810532 - Dystalic has fallen below 50 - e.g., see Monday 140428 reported
810533 - in case study on 120101 0900. ref SDS 21 CB6N
810535 - ..
810536 - 4. LDL-P 851 and HDL 67 and Triglycerides 59 on 140508, indicate
810537 - low risk for CVD, per above analysis, ref SDS 59 RV5M, and may
810538 - align with hiking 22 miles yesterday on 140507, and 11 miles
810539 - this morning at 0400 (see again case study - ref SDS 21 4G5I),
810540 - before doing the blood draw later this morning at 1149.
810541 - ref SDS 59 U45J
810543 - ..
810544 - 5. Lipid favorable results in NMR test on 140508, and follow up
810545 - test at VA on 140514, particularly increase HDL
810546 - occurred concurrent with...
810547 -
810548 - [On 140520 0732 letter notifies Doctor Alba at VA
810549 - getting good labs through prescribed care integrating
810550 - diet, exercise, and medications. ref SDS 64 4U46
810552 - ..
810553 - a. Hiking 955 miles since prior lab on 140203, reported in
810554 - case study 120101 0900, ref SDS 21 P36G, and recommended in
810555 - research on 131125 0005. ref SDS 46 QP9F including regular
810556 - aerobic exercise to lower triglycerides, ref SDS 46 U44L,
810557 - and raise HDL, ref SDS 46 SH50, and raise EPC production
810558 - toward regression of atherosclerosis plaque. ref SDS 46
810559 - 6O9M
810560 -
810561 - [On 140529 0942 letter asks VA to present record of care
810562 - that includes extended training exercise that yielded
810563 - significantly improved lipid labs. ref SDS 67 QF67
810565 - ..
810566 - b. Weight - hit 163 yesterday on 140513, shown in case study
810567 - on 120101 0900. ref SDS 21 ZU5G This is lowest is about 30
810568 - years. On 140420 was able to hold 165 for 3 days.
810569 - ref SDS 21 TO6O This is continuing challenge bouncing
810570 - around from over 200 in 2011, but varied significantly.
810571 - Daily weight remains generally between 170 - 175.
810573 - ..
810574 - c. Low-carbohydrate diet lowers triglycerides (TG 59 in
810575 - Labcorp and VA tests, per above, ref SDS 62 5C7M), which
810576 - together with higher HDL 67 (TG/HDL ratio .88 < 2,
810577 - ref SDS 62 5X5G, combine to lower LDL-P, cited in research
810578 - on 131125 0005. ref SDS 46 QP9F
810580 - ..
810581 - d. Chia seeds added to diet on 131125, reported in case study
810582 - on 120101 0900, ref SDS 21 746M, and recommended by Karen
810583 - at VA on 131121 0930. ref SDS 45 NQ37
810585 - ..
810586 - e. Orange juice 1 gallon (3786 ML) per week (541 ML/day) added
810587 - to diet on 131125, based on study indicating HDL increased
810588 - 21% over 4 weeks with 750 ml per day (i.e., 1.4 gal per
810589 - week), ref SDS 46 R48K, as reported to VA in letter on
810590 - 140114 0845. ref SDS 48 218O Some research also indicates
810591 - grape juice increases HDL; however, no studies have
810592 - quantified this effect. Patient consumes combination of
810593 - lemon juice, orange juice, and grape juice in large
810594 - quantities to hydrate after hiking 11 miles per day.
810596 - ..
810597 - HDL 50 increased to HDL 67 = 34% over 6 months from Dec
810598 - 2013 - May 2014, shown in patient history below.
810599 - ref SDS 62 W25L This is approximately 7% for each 4 week
810600 - period, which may reflect taking 541 ML of orange juice
810601 - rather than 750 ML per day. Raising HDL consistently 7%
810602 - over 4 weeks for 6 months taking only 541 ML in this case,
810603 - presents improved results compared to study results finding
810604 - 500 ML of orange juice for 4 weeks had no effect on HDL
810605 - levels. Improved results in this case may indicate that
810606 - orange juice at 540 ML/day combined with hiking 11 miles
810607 - per day, explained above (see para a), ref SDS 62 I17G,
810608 - provides a direct path to improve lipid profiles toward
810609 - avoiding and regressing atherosclerosis plaque.
810611 - ..
810612 - f. Atorvastatin 10 mg with Ezetimibe 10 begun on 131230,
810613 - reported in case study on 120101. ref SDS 21 6A6H
810615 - ..
810616 - Research studies report Atorvastatin 10 mg + Ezetimibe 10
810617 - mg achieves LDL < 70, and favorably changes triglycerides
810618 - and HDL by 5%, reported on 131125 0005. ref SDS 46 CO45
810619 - While low LDL < 70 conflicts with goal of "discordance"
810620 - that lowers health risk for arterialsclorosis and CVD when
810621 - LDL-P low and LDL-C high, shown in research on 131125 0005,
810622 - ref SDS 46 FI3G, even "concordant" results today are good
810623 - news.
810625 - ..
810626 - Since prior lab on 140201, until lab at VA today on 140508,
810627 - case study shows on 120101, ref SDS 21 E47L, patient has
810628 - taken...
810629 -
810630 - 1. Atorvastatin............... 900 mg
810631 - 2. Ezetimibe.................. 900 mg
810632 -
810634 - ..
810635 - Lipid History Trend Analysis
810636 -
810637 - Follow up ref SDS 68 W25L, ref SDS 62 W25L.
810638 -
810639 - Small LDL LP-IR
810640 - Collection DT CHOL TRIGL HDL LDL-C LDL-P HDL-P LDL-P SIZE SCORE LDL-D
810641 - 08/14/2014 15:28 161 72 55 92 ......................................... ref SDS 0 BE6O
810642 - 05/14/2014 10:16 164 58 66 87 .................................... 93.. ref SDS 62 BE6O
810643 - 05/08/2014 11:49 162 59 67 83 851 38.1 < 90 21.2 < 25 ..... ref SDS 59 BE6O
810644 - 02/03/2014 12:28 160 H 47 58 93 ......................................... ref SDS 52 BE6O
810645 - 02/01/2014 12:31 156 68 61 81 861 31.4 < 90 21.3 < 25 ..... ref SDS 51 BE6O
810646 - 10/15/2013 08:25 321 H 109 50 249 H ......................................... ref SDS 40 BE6O
810647 - 05/29/2013 08:18 307 H 85 50 240 H ......................................... ref SDS 36 BE6O
810648 - 02/28/2013 08:39 310 H 73 47 248 H ......................................... ref SDS 36 BE6O
810649 - 11/30/2012 10:01 173 53 57 105 ......................................... ref SDS 31 BE6O
810650 - 08/31/2012 15:25 176 94 47 110 ......................................... ref SDS 27 U89N
810651 - 05/09/2012 11:24 158 76 49 94 ......................................... ref SDS 26 U89N
810652 - 02/09/2012 11:18 285 82 41 228 H ......................................... ref SDS 22 2A4G
810653 - 11/17/2011 14:27 260 84 43 200 H ......................................... ref SDS 20 2A4G
810654 - 07/27/2011 12:58 163 81 45 102 ......................................... ref SDS 16 E19L
810655 - 12/07/2010 09:17 151 41 47 96 ......................................... ref SDS 15 E19L
810656 - 07/21/2010 08:54 261 H 87 35 L 209 H ......................................... ref SDS 11 E19L
810657 - 06/10/2010 10:33 217 H 83 36 L 164 H ......................................... ref SDS 10 QV4F
810658 - * 12/14/2009 11:10 241 H 136 44 170 H ......................................... 100928 0706, ref SDS 12 VW6J
810659 - 08/13/2009 15:09 233 H 118 30 L 179 H ......................................... 100610 1046, ref SDS 10 U45G
810660 - 06/16/2006 10:59 238 H 68 32 L 192 H ......................................... 091002 0900, ref SDS 6 LJ5H
810661 -
810662 - * Lab at VA San Francisco Medical Center reported on 100928 0706.
810663 - ref SDS 12 VW6J
810665 - ..
810666 - Research on cholesterol reported on 091002 0900. ref SDS 6 2F8K
810668 - ..
810669 - On 131125 0005 research found ezetimibe (zetia) mg added to
810670 - Atorvastatin 20 mg yielded after 6 weeks significantly greater changes
810671 - to lipids than taking Atorvastatin in higher doses, e.g., 20 or 40 mg.
810672 - ref SDS 46 CO56
810674 - ..
810675 - On 131125 0005 research found discordance LDL-P low and LDL-C high
810676 - lipid panel HDL 65 TG 77 healthy patient profile with LDL 246.
810677 - ref SDS 46 MN98 Discordance with LDL-P low and LDL-C high is lowest
810678 - risk for CVD, arterialsclorosis. ref SDS 46 FI3G
810679 -
810680 -
810682 - ..
810683 - Coronary CTA or IVUS Test Athereosclerosis Plaque 4 Years After CABG
810684 - Athereosclerosis Plaque 4 Years After CABG Coronary CTA or IVUS Test
810685 -
810686 - Follow up ref SDS 68 QA4M, ref SDS 62 QA4M.
810687 -
810688 - On 131125 0005 research further found radiology imaging tests can
810689 - evaluate level of plaque build up resulting from elevated cholesterol.
810690 - ref SDS 46 N73K Radiology imaging technologies are Coronary CT
810691 - angiography - CTA - and Intravascular ultrasound - IVUS. ref SDS 46
810692 - KZ8O
810694 - ..
810695 - Lipid history and particularly the past 6 months with HDL > 60 and
810696 - Triglycerides < 100, ref SDS 59 W25L, indicates patient may have change
810697 - body chemestry sufficient to cause rapid regression of atherosclerosis
810698 - plaque, cited in research on 131125 0005. ref SDS 46 RA7K Research
810699 - indicates that favorable lipid profile, weight loss, and production of
810700 - EPC in the bone marrow, all stimulated by exercise, drives regression
810701 - of plaque. ref SDS 46 XY7L
810703 - ..
810704 - The next step monitoring results of medical, diet, and exercise
810705 - interventions the past 4 years, since CABG +4 on 091022 0700,
810706 - ref SDS 7 PQWU, is to perform radiology imaging study with coronary CT
810707 - angiography or IVUS to assess regression of atherosclerosis plaque,
810708 - which previously required major surgery to fix.
810710 - ..
810711 - This step is supported by patient history using CT radiology imaging
810712 - to assess regression of esophageal bubble after 4 years of medical
810713 - interventions, reported favorable by Doctor Stewart, Chief General
810714 - Surgery at VA on 130122 1330. ref SDS 34 03H6
810715 -
810716 -
810717 -
810718 -
810719 -
810720 -
8108 -
SUBJECTS
VA Lab Cardiac Enzymnes Creatine Kinase CK also CPK Creatine Phospho
8903 -
890401 - ..
890402 - Myopathy Muscle Pain Side Effects Simvistatin Decline
890403 -
890404 - Follow up ref SDS 68 D26G, ref SDS 62 D26G.
890405 -
890406 - Prior Cardiac Enzymes Profile on 120209 1118. ref SDS 22 D26G
890407 - Prior Cardiac Enzymes Profile on 120509 1108. ref SDS 26 D26G
890408 - Prior Cardiac Enzymes, 131015 0724, ref SDS 40 D26G
890409 - Prior Cardiac Enzymes Profile VA on 140203 1147. ref SDS 52 NX6G
890411 - ..
890412 - This test not performed by Labcorp with blood draw on 140508...
890413 -
890414 - CARDIAC ENZYMES
890415 -
890416 - Dates 2014 05 14 1016 140508 140203 131015 120509
890417 - VA Labcorp VA VA VA
890418 - PLASMA Results Results Results Results Results Units Range
890419 - CPK (CK) 192 149 110 152 U/L 30 - 235
890420 - TRPONIN ng/ml 0 - 0.07
890421 - CK-MB ng/ml 0.6 - 3.5
890422 - MYOGLOB ng/ml 20 - 82
890424 - ..
890425 - a. CPK/CK test not performed by Labcorp
890427 - ..
890428 - b. SLIGHTLY ICTERIC SPECIMEN /HN
890430 - ..
890431 - c. Ordering Provider: Diana Alba
890432 - Report Released..: May 14, 2014@11:29
890433 - Reporting Lab....: SAN FRANCISCO VAMC [CLIA# 05D0988226]
890434 - 4150 CLEMENT STREET
890435 - SAN FRANCISCO, CA 94121-1545
890436 - Performing Lab...: SAN FRANCISCO VAMC [CLIA# 05D0988226]
890438 - ..
890439 - CKP and CK are the same thing - creatine phosphokinase (CPK) also
890440 - called creatine kinase (CK).
890441 -
890442 - http://www.scai.org/SecondsCount/Resources/Detail.aspx?cid=ed385473-d4e8-491e-9ce0-a7c984fe6f8e#.U3b_BfldWi8
890444 - ..
890445 - Research on 111013 explains Creatine Kinase CK, relates to muscle
890446 - disorders caused by cholesterol medications with statins. 111013 1404,
890447 - ref SDS 19 J54K
890449 - ..
890450 - CK lab may align with reduced side effects of muscle pain in left
890451 - shoulder.
890452 -
890453 -
890454 -
890455 -
890456 -
890457 -
8905 -
SUBJECTS
HGBA1C 5.4 Range 4.0-6.0 Diabetes Negative Laboratory Blood Test Cro
A603 -
A60401 - ..
A60402 - HGBA1c Diabetes Blood Test A1c
A60403 - A1c Diabetes Blood Test HGBA1c
A60404 - Diabetes HGBA1c A1c Blood Test
A60405 -
A60406 - Follow up ref SDS 68 9F4O, ref SDS 62 9F4O.
A60407 -
A60408 - Prior HGBA1c Profile on 100721 0800. ref SDS 11 IL4N
A60409 - Prior HGBA1c Profile on 101207 0906. ref SDS 15 IL4N
A60410 - Prior HGBA1c Profile on 131015 0724. ref SDS 40 9F4O
A60411 - Prior HGBA1c Profile on 140203 1147. ref SDS 52 9F4O
A60413 - ..
A60414 - This test not performed by Labcorp with blood draw on 140508...
A60416 - ..
A60417 - Endocrine IV - HGBA1c - A1c
A60418 -
A60419 - Dates..........2014 05 14 1016 140508 140203 131015 101207
A60420 - Dates..........2014 08 14 1528 140514 140508 140203 131015 101207
A60421 - VA VA Labcorp VA VA VA
A60422 - BLOOD Results Results Results Results Results Results Units Range
A60423 - HGBA1c 5.6 5.4 5.5 5.5 5.7 % 4.0 - 6.0
A60424 - eAG 114 111 111 mg/dL 74.0 - 118
A60426 - ..
A60427 - Comments:
A60428 -
A60429 - a. Labcorp did not perform HGBA1c lab
A60430 -
A60431 - b. Ordering Provider: Diana Alba
A60432 - Report Released..: May 14, 2014@11:29
A60433 - Reporting Lab....: SAN FRANCISCO VAMC [CLIA# 05D0988226]
A60434 - 4150 CLEMENT STREET
A60435 - SAN FRANCISCO, CA 94121-1545
A60436 - Performing Lab...: SAN FRANCISCO VAMC [CLIA# 05D0988226]
A60438 - ..
A60439 - This test for diabetes was ordered by Doctor Abrams during a meeting
A60440 - at the San Francisco VA Medical Center on 130227 0930. ref SDS 35 8T5L
A60441 - However, it is not reported for the lab performed the next day on
A60442 - 130228 1140, ref SDS 36 RP4N, nor in the follow up lab 3 months later
A60443 - on 130529 0818. ref SDS 38 RP4N
A60445 - ..
A60446 - HGBA1c was performed previously on 101207 0906, ref SDS 15 IL4N, and 5
A60447 - months earlier on 100721 0800. ref SDS 11 IL4N
A60449 - ..
A60450 - Labcorp test showing LP-IR Score < 25.0, indicating very low risk of
A60451 - diabetes, reported on 140508. ref SDS 59 TU6L
A60453 - ..
A60454 - Glucose 97 near upper range 79 99, Labcorp electrolyte panel last week
A60455 - on 140508, per above, ref SDS 62 ZG5O, indicates potential diabetes
A60456 - risk, but may be elevated by dehydration from statin medication and
A60457 - hiking 22 miles the day before the lab and 11 miles the morning before
A60458 - getting the blood draw, reported on 140508 1133. ref SDS 59 QW6K
A60459 -
A60460 -
A60461 -
A60462 -
A60463 -
A60464 -
A60465 -